The Lancet Regional Health. Europe (Apr 2022)
Concerns about the external validity of the study ‘Prevalence of persistent symptoms after treatment for Lyme borreliosis: A prospective observational cohort study’
Abstract
No abstracts available.
The Lancet Regional Health. Europe (Apr 2022)